Natural Capsules Limited — Board Meeting, 04-08-2025: Outcome of Board Meeting

Natural Capsules' board has approved the consolidated financial results for the quarter ended June 30, 2025. Consolidated revenue from operations grew to Rs 45.20 Cr from Rs 39.18 Cr year-on-year. However, the company reported a net loss of Rs 5.58 Cr (EPS of -5.40) compared to a profit of Rs 0.60 Cr (EPS of 0.65) in the prior year. The significant loss stems from its API subsidiary, Natural Biogenex, which recently commenced operations. While this unit's expenses are fully accounted for, its revenue generation is still ramping up.